WHAT DO WE DO ?
Developing breakthrough vaccines, therapeutics and diagnostics for infectious diseases with serious unmet patient needs. Employing proprietary technologies for oral, nasal, and mucosal vaccine administration. In addition, creating novel targeting aptamers.
WHO ARE WE ?
International biotech with experienced team that have successfully taken several therapeutics and diagnostics to market, and invented multiple drug formulation/delivery technologies.
Rapid ultrasensitive point-of-care diagnostic
Following positive research on MERS backed by InnovateUK
Employing a proprietary immunostimulatory nanoparticle carrier
Specific aptamer blocking infection